Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?

Código QR

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?

Guardado en:

Detalles Bibliográficos
Autores principales:	Ömer Faruk Bahçecioğlu, Selim Gök, Mefküre Durmuş, Ahmet Sarıcı
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/39cf0701b5324bfe8cb46ebb648b08c2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

OUTCOMES OF ALLOGENEIC SC TRANSPLANT IN HEMATOLOGICAL MALIGNANCY PATIENTS USING BUSULFAN 3 (9.6 MG/KG) BASED CONDITIONING REGIMEN
por: Majed Altareb, et al.
Publicado: (2021)

THE ROLE OF THERAPEUTIC DRUG MONITORING OF INTRAVENOUS BUSULFAN FOR PREVENTION OF SINUSOIDAL OBSTRUCTION SYNDROME IN CHILDREN
por: Dilek GURLEK GOKCEBAY, et al.
Publicado: (2021)

EVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION
por: Ayse Gunay, et al.
Publicado: (2021)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Natali Pflug, et al.
Publicado: (2021)

HAPLOIDENTICAL VERSUS UNRELATED ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADULTS WITH ACUTE LEUKEMIA
por: Arnon Nagler
Publicado: (2021)

INVESTIGATION OF DRUG-DRUG INTERACTIONS INVOLVING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Ayse Gunay, et al.
Publicado: (2021)

Cyclophosphamide-glucocorticoids versus lenalidomide-dexamethasone as treatment for multiple myeloma at first relapse after autologous stem cell transplantation – a retrospective analysis
por: Russell Sterrett, et al.
Publicado: (2021)

COMPARABLE OUTCOMES OF ALLOGENEIC PERIPHERAL BLOOD VERSUS BONE MARROW HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN
por: AYÇA KOCA YOZGAT, et al.
Publicado: (2021)

Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host
por: Uroosa Ibrahim, et al.
Publicado: (2021)

PILOMATRIX CARCINOMA WAS BEYOND ANY EXPECTATIONS: A CASE REPORT OF CARCINOMA CLINICIAN SHOULD BE AWARE OF IT
por: Abdalraouf Omar, et al.
Publicado: (2021)

Novel conditioning regimens for bone marrow transplantation
por: Shi M, et al.
Publicado: (2013)

Unexpected debris after post thawing donor stem cells in autologous transplantation
por: Basak Adaklı Aksoy, et al.
Publicado: (2021)

IMPACT OF BONE MARROW FIBROSIS IN MYELOMA PATIENTS UNDERGONE AUTOLOGOUS STEM CELL TRANSPLANTATION
por: Senem Maral, et al.
Publicado: (2021)

A CASE OF REFRACTORY IMMUNE THROMBOCYTOPENIA APPLIED WITH AUTOLOGOUS HEMATOPOETIC STEM CELL TRANSPLANTATION
por: Mine KARADENIZ, et al.
Publicado: (2021)

THE OUTCOME OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD AND THE RISK FACTORS FOR CHRONICITY
por: Barış YILMAZ, et al.
Publicado: (2021)

Gemtuzumab ozogamicin is efficacious in attaining complete remission in relapsed/refractory acute leukemia prior to hematopoietic cell transplant: A case series
por: Giancarlo Fatobene, et al.
Publicado: (2021)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
por: Eko A. Pangarsa, et al.
Publicado: (2021)

Bone marrow necrosis in a patient with advanced Hodgkin's lymphoma after G-CSF and Plerixafor treatment during harvesting for autologous bone marrow transplantation: is it possible?
por: Najmaddin Khoshnaw, et al.
Publicado: (2021)

A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
por: David MARKS, et al.
Publicado: (2021)

MANAGEMENT AND OUTCOMES OF NEUTROPENIA IN PREVIOUSLY HEALTHY CHILDREN
por: Hatice Mine Cakmak, et al.
Publicado: (2021)

THE EFFECT OF NIVOLUMAB IN PEDIATRIC MALIGNANT TUMORS: A SINGLE CENTER EXPERIENCE WITH EIGHT PATIENTS
por: Veysel GOK, et al.
Publicado: (2021)

EVALUATION OF CLINICAL AND LABORATORY CHARACTERISTICS OF CHILDREN WITH RHABDOID TUMOR: A MULTICENTER STUDY
por: Firdevs AYDIN, et al.
Publicado: (2021)

CAVITARY PRIMARY PULMONARY LYMPHOPLASMOCYTIC LYMPHOMA COMPLICATING HENOCH–SCHÖNLEIN PURPURA
por: Burak GULTEKIN, et al.
Publicado: (2021)

VENETOCLAX AZACITIDINE COMBINATION THERAPY IN FIRST-LINE TREATMENT OF ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE
por: Melda Cömert, et al.
Publicado: (2021)

ONC 201 PRACTICE IN DIFFUSE MIDLINE GLIOMA (H3K27M MUTANT)
por: Bahattin Tanrıkulu, et al.
Publicado: (2021)

THERAPEUTIC PLASMA EXCHANGE IN PATIENTS WITH NEUROLOGICAL DISEASES: A 9-YEAR, SINGLE-CENTER EXPERIENCE
por: Merih Reis Aras, et al.
Publicado: (2021)

EVALUATION OF THE RELATIONSHIP OF ABO BLOOD GROUPS WITH MIS-C
por: Fatma Burçin KURTİPEK, et al.
Publicado: (2021)

THE IMPACT OF TYROSINE KINASE INHIBITORS ON FATHERHOOD IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA, A SINGLE INSTITUTION EXPERIENCE
por: Mohammad Abu-Tineh, et al.
Publicado: (2021)

CHILDHOOD IMMUNE THROMBOCYTOPENIA: A MULTICENTER QUESTIONNAIRE STUDY
por: Ayşegül Ünüvar, et al.
Publicado: (2021)

A NOVEL MISSENSE MUTATION OUTSIDE DNAJ DOMAIN OF DNAJC21 IS ASSOCIATED WITH SHWACHMAN-DIAMOND SYNDROME
por: Mohammad Bilal Alsavaf, et al.
Publicado: (2021)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
por: Zhang CL, et al.
Publicado: (2012)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
por: Lim EL, et al.
Publicado: (2013)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
por: Bodiford A, et al.
Publicado: (2015)

The expanding role of bendamustine in chronic lymphocytic leukemia
por: Nair KS, et al.
Publicado: (2015)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Raffaella Pasquale, et al.
Publicado: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
por: Monarch Shah, et al.
Publicado: (2021)

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
por: Jennifer Gill, et al.
Publicado: (2020)

All bleeding matters … but the details may not
por: Sarah H. O’Brien
Publicado: (2020)

PP Transcon 2020 Abstracts Compilation
Publicado: (2021)

Positive/external control of rapid diagnostic tests: A step forward in malaria screening
por: Rasika D Setia, et al.
Publicado: (2021)